Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
The Cochrane Database of Systematic Reviews
|
July 26, 2002
Carbamazepine for schizophrenia and schizoaffective psychoses
S Leucht, J McGrath, P White, et al.
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Carbamazepine for schizophrenia and schizoaffective psychoses
S Leucht, J McGrath, P White, et al.
Psychopharmacology
|
July 4, 2001
Dropout rates in randomised antipsychotic drug trials
K Wahlbeck, A Tuunainen, A Ahokas, et al.
Pharmacopsychiatry
|
December 10, 2003
Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists
J Hamann, H Pfeiffer, S Leucht, et al.
The Pharmacogenomics Journal
|
March 12, 2008
DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
J Popp, S Leucht, S Heres, et al.
The Cochrane Database of Systematic Reviews
|
January 27, 2007
Benzodiazepines for schizophrenia
A Volz, V Khorsand, D Gillies, et al.
Der Nervenarzt
|
October 26, 2007
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview]
B Voss, R Thienel, S Leucht, et al.
The Cochrane Database of Systematic Reviews
|
July 20, 2007
Carbamazepine for schizophrenia
S Leucht, W Kissling, J McGrath, et al.
The Cochrane Database of Systematic Reviews
|
January 28, 2005
Perphenazine for schizophrenia
B Hartung, M Wada, G Laux, et al.
Der Nervenarzt
|
July 16, 2003
[Fugue and suicide]
S Leucht, S Mirisch, T Etgen, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
The Cochrane Database of Systematic Reviews
|
July 26, 2002
Carbamazepine for schizophrenia and schizoaffective psychoses
S Leucht, J McGrath, P White, et al.
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Carbamazepine for schizophrenia and schizoaffective psychoses
S Leucht, J McGrath, P White, et al.
Psychopharmacology
|
July 4, 2001
Dropout rates in randomised antipsychotic drug trials
K Wahlbeck, A Tuunainen, A Ahokas, et al.
Pharmacopsychiatry
|
December 10, 2003
Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists
J Hamann, H Pfeiffer, S Leucht, et al.
The Pharmacogenomics Journal
|
March 12, 2008
DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
J Popp, S Leucht, S Heres, et al.
The Cochrane Database of Systematic Reviews
|
January 27, 2007
Benzodiazepines for schizophrenia
A Volz, V Khorsand, D Gillies, et al.
Der Nervenarzt
|
October 26, 2007
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview]
B Voss, R Thienel, S Leucht, et al.
The Cochrane Database of Systematic Reviews
|
July 20, 2007
Carbamazepine for schizophrenia
S Leucht, W Kissling, J McGrath, et al.
The Cochrane Database of Systematic Reviews
|
January 28, 2005
Perphenazine for schizophrenia
B Hartung, M Wada, G Laux, et al.
Der Nervenarzt
|
July 16, 2003
[Fugue and suicide]
S Leucht, S Mirisch, T Etgen, et al.
Page
of 8